28 related articles for article (PubMed ID: 35868048)
21. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
22. Identification of chromosomal instability-associated genes as hepatocellular carcinoma progression-related biomarkers to guide clinical diagnosis, prognosis and therapy.
Hu Y; Tang C; Zhu W; Ye H; Lin Y; Wang R; Zhou T; Wen S; Yang J; Fang C
Comput Biol Med; 2022 Sep; 148():105896. PubMed ID: 35868048
[TBL] [Abstract][Full Text] [Related]
23. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes.
Chen W; Tang D; Ou M; Dai Y
DNA Cell Biol; 2020 Apr; 39(4):499-512. PubMed ID: 32069130
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic molecular markers in hepatocellular carcinoma.
MÃnguez B; Lachenmayer A
Dis Markers; 2011; 31(3):181-90. PubMed ID: 22045404
[TBL] [Abstract][Full Text] [Related]
25. Novel biomarkers and strategies for HCC diagnosis and care.
Wang AE; Leven EA; Grinspan LT; Villanueva A
Clin Liver Dis (Hoboken); 2024; 23(1):e0152. PubMed ID: 38707238
[No Abstract] [Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
